Table 3.
Treatment | Time |
||||||
---|---|---|---|---|---|---|---|
0 | 6 | 12 | 18 | 24 | 48 | 72 | |
−ve control | 9a ± 0 | 11.75a ± 1.25 | 13.50a ± 0.29 | 15.75b ± 1.44 | 16.25b ± 0.85 | 17.25b ± 1.11 | 20.50c ± 0.65 |
+ve Control at MIC | 9a ± 0 | 10a ± 0.41 | 10.5a ± 0.29 | 10.75a ± 0.63 | 9.25a ± 0.48 | 9a ± 0.41 | 8.5a ± 0.29 |
+ve control at MBC | 9a ± 0 | 8.75a ± 0.48 | 8.5a ± 0.29 | 7.75a ± 0.49 | 7.75a ± 0.49 | 7.25a ± 0.25 | 7a ± 0.4 |
Plant extract at MIC | 9a ± 0 | 9.75a ± 0.25 | 10a ± 0.41 | 10.5a ± 0.66 | 10a ± 0.41 | 9.5a ± 0.65 | 9a ± 0.4 |
Plant extract at MBC | 9a ± 0 | 9a ± 0.41 | 8.75a ± 0.75 | 8.5a ± 0.65 | 8.5a ± 0.66 | 8a ± 0.41 | 7.25a ± 0.25 |
(1) −ve control = S. mutans in MHB; +ve control = Gentamicin (7.5 µg/ml MIC and 15 µg/ml MBC); Plant extract Shih (2.5 mg/ml MIC and 4 mg/ml MBC).
(2) Values are mean ± Standard error.
(3) Values in the same row and same time period bearing the same superscript do not differ significantly (P < 0.05).